HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED Hansoh Pharmaceutical Group Company Limited Share Price Deutsche Boerse AG
Equities
3KY
KYG549581067
Pharmaceuticals
|
Market Closed -
Other stock markets
|
After market 20:51:55 | |||
| 1.88 EUR | -3.59% |
|
1.955 | +3.99% |
| 04-30 | Hansoh Pharmaceutical’s 2023 Profit Up 27% | MT |
| 04-29 | Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 | CI |
| Sales 2024 * | 11.82B 1.63B 1.5B 128B | Sales 2025 * | 12.49B 1.72B 1.59B 135B | Capitalization | 91.34B 12.61B 11.61B 988B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.74B 517M 476M 40.48B | Net income 2025 * | 3.81B 526M 484M 41.21B | EV / Sales 2024 * | 5.93 x |
| Net cash position 2024 * | 21.23B 2.93B 2.7B 230B | Net cash position 2025 * | 23.86B 3.29B 3.03B 258B | EV / Sales 2025 * | 5.4 x |
| P/E ratio 2024 * |
24
x | P/E ratio 2025 * |
23.8
x | Employees | 9,123 |
| Yield 2024 * |
1% | Yield 2025 * |
1.03% | Free-Float | 18.24% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +0.26% | ||
| 1 week | -12.15% | ||
| Current month | -9.62% | ||
| 1 month | -7.84% | ||
| 3 months | +21.29% | ||
| 6 months | +14.63% | ||
| Current year | +14.63% |
1 week
1.88
2.02
1 month
1.882.16
Current year
1.322.16
1 year
1.112.16
3 years
1.113.80
5 years
1.114.88
10 years
1.114.88
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 01/12/15 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 30/05/19 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 13/06/19 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 1.88 | -3.59% |
| 24/05/24 | 1.95 | -3.47% |
| 23/05/24 | 2.02 | +1.00% |
| 22/05/24 | 2 | 0.00% |
| 21/05/24 | 2 | -6.54% |
Delayed Quote Deutsche Boerse AG, May 28, 2024 at 02:29 pm
More quotes
Hansoh Pharmaceutical Group Company Limited specializes in the development, manufacture and marketing of pharmaceutical products for the treatment of tumor, infectious, metabolic and autoimmune diseases. Net sales break down by revenue source as follows:
- sales of pharmaceutical products (99.1%);
- sales of research and development services (0.9%).
Sector
Pharmaceuticals
Calendar
28/08/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
15.42
CNY
Average target price
17.81
CNY
Spread / Average Target
+15.55%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +38.59% | 727B | |
| -7.89% | 354B | |
| +15.66% | 328B | |
| +0.24% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +4.23% | 164B | |
| -1.70% | 164B |
- Stock Market
- Equities
- 3692 Stock
- 3KY Stock
